FDA to review broader access to restricted peptides in July Peptides Are Legal. Here's What Actually Matters Now. COP Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction FDA Peptide Reclassification 2026: What Researchers Want The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step